Announcements
Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with MedReviews, LLC.
Open Access
Review
Heart Failure: Recent Advances in Prevention and Treatment
Show Less
1
University of California, Los Angeles, UCLA School of Medicine
Rev. Cardiovasc. Med. 2000, 1(1), 25;
Published: 30 March 2000
Abstract
The most important advance in heart failure treatment during the past decade has been the recognition that medications inhibiting neurohormonal activation relieve symptoms, reduce hospitalizations, and prolong survival in patients with heart failure from left ventricular systolic dysfunction. Recent trials with angiotensin-converting enzyme inhibitors, angiotensin receptor antagonists, aldosterone antagonists, and ß-blockers have provided valuable information regarding the uses, dosing, and extent of therapeutic benefits of neurohormonal inhibition.
Keywords
Aldosterone antagonists
Angiotensin-converting enzyme inhibitors
β-Blockers
Heart failure
congestive
Neurohormones